Bonaire, Sint Eustatius and Saba vs Curacao: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bonaire, Sint Eustatius and Saba
0.2%
in 2024
Curacao
0.2%
in 2024
Bonaire, Sint Eustatius and Saba rank
99th
Curacao rank
99th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bonaire, Sint Eustatius and Saba
- Curacao
How they compare
Bonaire, Sint Eustatius and Saba currently reports 0.2% against 0.2% in Curacao, a difference of 0.0%.
Across all 10 years both countries report, Curacao has been ahead every year.
Bonaire, Sint Eustatius and Saba ranks 99th and Curacao ranks 99th of 247 countries.
Head to head by decade
| Decade | Bonaire, Sint Eustatius and Saba | Curacao | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bonaire, Sint Eustatius and Saba or Curacao?
- Bonaire, Sint Eustatius and Saba, at 0.2% against 0.2% in Curacao as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bonaire, Sint Eustatius and Saba and Curacao?
- 0.0%, with Bonaire, Sint Eustatius and Saba ahead.
- How many years of comparable data are there for Bonaire, Sint Eustatius and Saba and Curacao?
- 10 years are reported by both, from 2015 to 2024.
- How do Bonaire, Sint Eustatius and Saba and Curacao rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bonaire, Sint Eustatius and Saba ranks 99th and Curacao ranks 99th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.